A detailed history of Global Assets Advisory, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Global Assets Advisory, LLC holds 2,285 shares of LLY stock, worth $1.75 Million. This represents 1.11% of its overall portfolio holdings.

Number of Shares
2,285
Previous 577 296.01%
Holding current value
$1.75 Million
Previous $522 Million 286.87%
% of portfolio
1.11%
Previous 0.83%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$772.14 - $960.02 $1.32 Million - $1.64 Million
1,708 Added 296.01%
2,285 $2.02 Billion
Q2 2024

Jul 30, 2024

SELL
$724.87 - $909.04 $303 Million - $380 Million
-417,726 Reduced 99.86%
577 $522 Million
Q1 2024

Apr 12, 2024

BUY
$592.2 - $792.28 $248 Million - $331 Million
418,303 New
418,303 $550,000
Q3 2023

Oct 04, 2023

BUY
$434.7 - $599.3 $218,219 - $300,848
502 New
502 $269,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Global Assets Advisory, LLC Portfolio

Follow Global Assets Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Assets Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Assets Advisory, LLC with notifications on news.